Pharmaceutical composition of hiv-protease inhibitors

Details Pharmaceutical composition of hiv-protease inhibitors Pharmaceutical composition of hiv-protease inhibitors

A - Human Necessities

61

K

A61K 31/427 (2006.01) A61K 9/48 (2006.01) A61K 31/00 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/47 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61K 31/496 (2006.01) A61K 31/551 (2006.01) A61K 31/635 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2167412

A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a pharmaceutically acceptable alcohol. The composition can optionally comprise a pharmaceutically acceptable acid or a combination of pharmaceutically acceptable acids. The solution can optionally be encapsulated in hard gelating capsule or soft elastic gelating capsules. The solution can optionally be granulated with a pharmaceutically acceptable granulating agent.

Composition pharmaceutique comprenant une solution d'un composé inhibiteur de la protéase du VIH dans un solvant organique consistant en un alcool pharmacocompatible. Ladite composition qui peut comporter éventuellement un acide ou une combinaison d'acides pharmacocompatibles peut éventuellement être encapsulée dans des gélules de gélatine dure ou molle, ou mise sous forme de granulés à l'aide d'un agent de granulation pharmacocompatible .

Affiliated with

Also associated with

Rating

Pharmaceutical composition of hiv-protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition of hiv-protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of hiv-protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1771844